Table 5. Area under curve for four models.
Model 1 = clinical* | Model 2 = clinical+top locus** | Model 3 = clinical+GRS | Model 4 = clinical+sub-GRS | p-value model 4 versus 1 | p-value model 4 versus 2 | p-value model 4 versus 3 | |
anti-dsDNA antibodies | 0.581 | 0.600 | 0.636 | 0.655 | 2.1E–7 | 3.4E–5 | 0.020 |
age at diagnosis<34 years | 0.512 | 0.547 | 0.560 | 0.580 | 0.0080 | 0.0093 | 0.12 |
renal disorder | 0.646 | 0.656 | 0.657 | 0.656 | 0.11 | 1 | 0.90 |
oral ulcers | 0.510 | 0.552 | 0.578 | 0.595 | 1.0E–6 | 0.0027 | 0.12 |
hematologic disorder | 0.563 | 0.571 | 0.584 | 0.601 | 0.0097 | 0.030 | 0.12 |
immunologic disorder | 0.580 | 0.590 | 0.621 | 0.633 | 0.00049 | 0.0019 | 0.26 |
*disease duration and sex for all except early diagnosis; sex only for early diagnosis.
**top locus adjusting for sex and duration: anti-dsdna, early diagnosis, oral ulcers = STAT4; renal = HLA-DR3; immunologic = KIAA1542; hematologic = UBE2L3.